Targeting Pathogenic Fibroblasts with RNA-Engineered T Cells - CV Live: At the Cutting Edge of Cardiovascular Sciences

Join this hour-long cardiovascular sciences webinar featuring guest presenter Dr. Joel Rurik from the Karolinska Institute as he discusses "Targeting Pathogenic Fibroblasts with RNA-Engineered T Cells." Learn about cutting-edge research and innovations in cardiovascular treatment approaches during this CV Live session presented by Houston Methodist DeBakey CV Education.